Current Research Information SysTem In Norway
 
 

 Norsk versjon


 
Mainpage
Research results/NVI
Researchers
Projects
Research units
Log in
About Cristin
 
 
   
Back to search     Short format     Full format    
Export to


Search criteria:
From: 2000   To: 2099   Unit: Gynekologisk onkologisk forskningsgruppe (UiT)   Main category: Journal publication   All publishing channels

Showing results 1-20 of 20

2019
1 Sletten, Elise Thoresen; Arnes, Marit; Lyså, Lena Marianne Myreng; Larsen, Marthe; Ørbo, Anne.
Significance of progesterone receptors (PR-A and PR-B) expression as predictors for relapse after successful therapy of endometrial hyperplasia: a retrospective cohort study. BJOG: an International Journal of Obstetrics and Gynaecology 2019 p. 1-8
UiT UNN Untitled
 
2 Sletten, Elise Thoresen; Arnes, Marit; Vereide, Anne Beate; Ørbo, Anne.
Intrauterine progestin therapy as a new approach to premalignant endometrial polyps: A prospective observational study. Anticancer Research 2019 ;Volume 39.(9) p. 4897-4903
UiT UNN Untitled
 
2018
3 Sletten, Elise Thoresen; Arnes, Marit; Vereide, Anne Beate; Ørbo, Anne.
Low-dose LNG-IUS as therapy for endometrial hyperplasia. A prospective cohort pilot study. Anticancer Research 2018 ;Volume 38.(5) p. 2883-2889
UiT UNN Untitled
 
2017
4 Sletten, Elise Thoresen; Arnes, Marit; Lyså, Lena Marianne Myreng; Moe, Bjørn Thorvald Greve; Straume, Bjørn; Ørbo, Anne.
Prediction of relapse after therapy withdrawal in women with endometrial hyperplasia: A long-term follow-up study. Anticancer Research 2017 ;Volume 37.(5) p. 2529-2536
UiT UNN Untitled
 
2016
5 Ørbo, Anne; Arnes, Marit; Lyså, Lena Marianne Myreng; Borgfelt, Christer; Straume, Bjørn.
HE4 is a novel tissue marker for therapy response and progestin resistance in medium- and low-risk endometrial hyperplasia. British Journal of Cancer 2016 ;Volume 115.(6) p. 725-730
UiT UNN Untitled
 
6 Ørbo, Anne; Arnes, Marit; Vereide, Anne Beate; Straume, Bjørn.
Relapse risk of endometrial hyperplasia after treatment with the levonorgestrel-impregnated intrauterine system or oral progestogens. BJOG: an International Journal of Obstetrics and Gynaecology 2016 ;Volume 123.(9) p. 1512-1519
UiT UNN Untitled
 
2015
7 Ørbo, Anne; Arnes, Marit; Lyså, Lena Marianne Myreng; Straume, Bjørn.
Expression of PAX2 and PTEN correlates to therapy response in endometrial hyperplasia. Anticancer Research 2015 ;Volume 35.(12) p. 6401-6410
UiT UNN Untitled
 
2014
8 Arnes, Marit; Hvingel, Bodil; Ørbo, Anne.
Levonorgestrel-impregnated intrauterine device reduces occurrence of hyperplastic polyps: A population-based follow-up cohort study. Anticancer Research 2014 ;Volume 34.(5) p. 2319-2324
UiT UNN Untitled
 
9 Ørbo, Anne; Vereide, Anne Beate; Arnes, Marit; Pettersen, Inger; Straume, Bjørn.
Levonorgestrel-impregnated intrauterine device as treatment for endometrial hyperplasia: A national multicentre randomised trial. BJOG: an International Journal of Obstetrics and Gynaecology 2014 ;Volume 121.(4) p. 477-486
UiT UNN Untitled
 
2012
10 Eggen, Tormod; Sager, Georg; Berg, Thomas; Nergaard, Birgitte; Moe, Bjørn Torvald Greve; Ørbo, Anne.
Increased Gene Expression of the ABCC5 Transporter without Distinct Changes in the Expression of PDE5 in Human Cervical Cancer Cells during Growth. Anticancer Research 2012 ;Volume 32.(8) p. 3055-3061
UiT UNN Untitled
 
11 Hvingel, Bodil; Lieng, Marit; Roald, Borghild; Ørbo, Anne.
Vascular markers CD31, CD34, actin, VEGFB, and VEGFR2, are prognostic markers for malignant development in benign endometrial polyps. Open Journal of Obstetrics and Gynecology 2012 ;Volume 2. p. 18-26
OUS UiO UiT Untitled
 
2011
12 Eggen, Tormod; Sager, Georg; Arnes, Marit; Pettersen, Inger; Ørbo, Anne.
Expression of iNOS - A Favourable Prognostic Marker for Early-stage Carcinoma of the Uterine Cervix. Anticancer Research 2011 ;Volume 31.(6) p. 2319-2325
UiT UNN Untitled
 
13 Hellevik, Turid; Pettersen, Inger; Winberg, Jan-Olof; Berg, Vivian; Paulssen, Ruth H; Bartnes, Kristian; Busund, Lill-Tove; Bremnes, Roy M.; Martinez, Inigo Zubiavrre.
The Impact of Ionizing Radiation on the Motility and Matrix Remodelling Properties of Carcinoma-associated Fibroblasts. European Journal of Cancer 2011 ;Volume 47. p. S142-S143
UiT UNN Untitled
 
14 Ørbo, Anne; Arnes, marit; Pettersen, Inger; Larsen, Kurt; Hanssen, Karin Johanne; Moe, Bjørn Torvald Greve.
Successful treatment of endometrial hyperplasia by the levonorgestrel impregnated intrauterine system coincides with down-regulated progesterone receptor A and B. Virchows Archiv 2011 ;Volume 459. p. S256-S256
UiT Untitled
 
15 Ørbo, Anne; Moe, B; Pettersen, I; Arnes, M; Hanssen, K.
Diagnostics of coexistent endometrial carcinoma in high-risk endometrial hyperplasia: significance of the 4c-rule and EIN for outcome prediction. Virchows Archiv 2011 ;Volume 459. p. S29-S29
UiT Untitled
 
2010
16 Fjelldal, Renathe; Moe, Bjørn Torvald Greve; Ørbo, Anne; Sager, Georg.
MCF-7 Cell Apoptosis and Cell Cycle Arrest: Non-genomic Effects of Progesterone and Mifepristone (RU-486). Anticancer Research 2010 ;Volume 30.(12) p. 4835-4840
UiT Untitled
 
17 Rinne, ari ensio.
Epidermal SH-protease inhibitor (ACPI, cystatin A) in cancer. A short historical review. Pathology, Research and Practice 2010 ;Volume 206.(4) p. 259-262
UiT Untitled
 
18 Ørbo, Anne; Arnes, Marit; Pettersen, Inger; Larsen, Kurt; Hanssen, Karin Johanne; Moe, Bjørn Torvald Greve.
Down-regulated progesterone receptor A and B coinciding with successful treatment of endometrial hyperplasia by the levonorgestrel impregnated intrauterine system. Acta Obstetricia et Gynecologica Scandinavica 2010 ;Volume 89.(11) p. 1438-1446
UiT UNN Untitled
 
19 Ørbo, Anne; Moe, Bjørn Torvald Greve; Arnes, Marit; Pettersen, Inger; Larsen, Kari Margrethe; Eggen, Tormod; Myrmel, Kristin Smistad; Hanssen, Karin Johanne.
Prognostic markers for detection of coexistent carcinoma in high-risk endometrial hyperplasia. Anticancer Research 2010 ;Volume 30.(11) p. 4649-4655
UiT UNN Untitled
 
2009
20 Moe, Bjørn Torvald Greve; Vereide, Anne Beate; Ørbo, Anne; JÆger, ragnhild; Sager, Georg.
Levonorgestrel, Medroxyprogesterone and Progesterone Cause a Concentration-dependent Reduction in Endometrial Cancer (Ishikawa) Cell Density, and High Concentrations of Progesterone and Mifepristone Act in Synergy. Anticancer Research 2009 ;Volume 29.(4) p. 1047-1052
UiT Untitled